jain.com

File prospectus supplements for conversion shares within 30 days

Company: Nebius

This claim was marked delayed on September 3, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
regulatory
Statement date
2025-06-01
Promised by
2025-07-05
Current status
delayed

The claim, verbatim

Nebius will file prospectus supplements within 30 days after settlement of convertible notes to register Class A ordinary shares issuable upon conversion

Source (primary)

Nebius 6-K filed 2025-06-02 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗

Quote: “the Company will as promptly as practicable (but in no event more than thirty (30) days after the settlement of the Notes) file one or more prospectus supplements to the Company's shelf registration statement to register the Class A ordinary shares issuable upon conversion of the Notes”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms Nebius 6-K filed 2025-06-02

Quote: “the Company will as promptly as practicable (but in no event more than thirty (30) days after the settlement of the Notes) file one or more prospectus supplements to the Company's shelf registration statement to register the Class A ordinary shares issuable upon conversion of the Notes”

View cached copy (2026-08-31)Live source ↗

Record of changes

September 2, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 3, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.